Press Releases

Date Title and Summary Additional Formats
Toggle Summary Omnicell Reports Results for First Quarter 2019
GAAP and non-GAAP revenues of $202.5 million, up 10.9% year-over-year GAAP net income per diluted share of $0.08, up 14.3% year-over-year Non-GAAP net income per diluted share of $0.61, up 110.3% year-over-year MOUNTAIN VIEW, Calif. , April 25, 2019 /PRNewswire/ -- Omnicell, Inc....
View HTML
Toggle Summary Omnicell to Release First Quarter 2019 Earnings Results on April 25, 2019
MOUNTAIN VIEW, Calif. , April 18, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, April 25, 2019 , to discuss the Company's First...
View HTML
Toggle Summary Omnicell Reports Results for Fiscal Year and Fourth Quarter 2018
Record yearly GAAP revenues of $787.3 million Record yearly Non-GAAP revenues of $787.3 million 2018 GAAP net income per diluted share of $0.93 Record 2018 Non-GAAP net income per diluted share of $2.09 Record ending product backlog of $478 million MOUNTAIN VIEW, Calif. , Feb....
View HTML
Toggle Summary Omnicell to Release Fourth Quarter 2018 Earnings Results on February 7, 2019
MOUNTAIN VIEW, Calif. , Feb. 1, 2019 /PRNewswire/  --  Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 7, 2019 , to discuss the Company's...
View HTML
Toggle Summary Omnicell To Present At The 37th Annual J.P. Morgan Healthcare Conference
MOUNTAIN VIEW, Calif. , Dec. 27, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps , founder, chairman, president and CEO, and Peter...
View HTML
Toggle Summary Omnicell To Present At The 30th Annual Piper Jaffray Healthcare Conference
MOUNTAIN VIEW, Calif. , Nov. 14, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps , founder, chairman, president and CEO, and Peter Kuipers...
View HTML
Toggle Summary Omnicell Achieves Record Revenue in the Third Quarter 2018
GAAP revenues of $204 million, up 9.4% year-over-year GAAP net income per diluted share of $0.33, up 65% year-over-year Non-GAAP revenues of $204 million, up 9.2% year-over-year Non-GAAP net income per diluted share of $0.63, up 37% year-over-year MOUNTAIN VIEW, Calif. , Oct....
View HTML
Toggle Summary Omnicell to Release Third Quarter 2018 Earnings Results on October 25, 2018
MOUNTAIN VIEW, Calif. , Oct. 18, 2018 /PRNewswire/ --  Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, October 25, 2018 , to discuss the Company's...
View HTML
Toggle Summary Omnicell Announces Second Quarter 2018 Results
GAAP revenues of $189 million, up 4.2% year-over-year GAAP net income per diluted share of $0.16, up $0.11 year-over-year Non-GAAP revenues of $189 million, up 4.0% year-over-year Non-GAAP net income per diluted share of $0.46, up $0.13 year-over-year MOUNTAIN VIEW, Calif....
View HTML
Toggle Summary Omnicell to Release Second Quarter 2018 Earnings Results on July 26, 2018
MOUNTAIN VIEW, Calif. , July 19, 2018 /PRNewswire/ --   Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, July 26, 2018 to discuss the Company's Second...
View HTML